This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

Mumbai: Global pharma major, Lupin Limited, has announced that the Company has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...

Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur ...

Nilesh Gupta, MD, Lupin said, We are pleased to receive the EIR from the US FDA for our Pithampur Unit-1 facility with a satisfactory ... Mumbai-based Lupin is an innovation-led transnational ...

Lupin: Pharmaceutical company Lupin received an Establishment Inspection Report (EIR) from the US FDA for its Pithampur Unit-1 facility, which manufactures APIs and finished products. The EIR ...

Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Pithampur Unit-1 ...

Lupin's Pithampur manufacturing unit produces both APIs (Active Pharmaceutical Ingredients) and finished products ...